home

Professor von Itzstein Gold Coast Citizen of the Year

Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Published
Griffith Enterprise

New treatment for viral arthritis reveals impressive results in Phase 2 human clinical trial

Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Published
Griffith Enterprise

Meningococcal vaccine may reduce gonorrhoea incidence

A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby Institute at UNSW Sydney. The $2.7 million study incorporates five Australian universities and three health districts and providers, and will test whether a meningococcal B vaccine protects against gonorrhoea in gay and bisexual men. “Gonorrhoea […]
Published
Arts Education Law

Griffith awarded $3.3 million in funding for ARC Discovery and Linkage projects

Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.
Published
Griffith Enterprise

Griffith and China Grand Pharma sign landmark deal to develop new drug for parainfluenza virus

Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
Published
Griffith Enterprise

Researchers use deep learning method to delve into predicting RNA structures in world first

Method to better predict RNA secondary structures could become tool to better understand implication in various diseases such as cancer. 
Published
Griffith Enterprise

Mushroom extracts could offer an immune cell boost

Shiitake, Reishi, and Maitake extracts enhance immune cell responses to boost overall immune system.
Published
Griffith Enterprise

Potential vaccine treats and prevents deadly streptococcal toxic shock

A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year. “Streptococcal toxic shock syndrome is an acute condition like meningococcus – if you get exposed to the organism you can be dead […]
Published
Corporate

Griffith medical research to benefit from $5m funding 

NHMRC funding for Griffith researchers totals $5,167,963.
Published
Griffith Enterprise

Self-destructing cells could hold key for brain health and food security

‘Cell suicide’ study could unlock treatment for brain diseases and development of disease-resistant plants. 
Published
Architecture

Griffith scientists celebrate National Science Week 2019 

National Science Week will see a range of events celebrate Griffith's scientific expertise.
Published
Institute for Glycomics

Research provides new hope for treatment of Hand, Foot and Mouth Disease

A new scientific discovery, thanks to one of the research groups at Griffith University’s Institute for Glycomics, is providing new hope for the development of an effective treatment of Hand, Foot and Mouth Disease (HFMD). Led by the Institute’s Founder and Director, Professor Mark von Itzstein AO, the research group has just published a paper […]
Published
Institute for Glycomics

Institute for Glycomics receives US grant for vital cholera research

Griffith’s Institute for Glycomics will share in a significant US funded grant awarded by the National Institute for Health (NIH) for a two-year research project investigating the role of Vibrio cholerae (V. cholerae) in causing widespread cholera epidemics. V. cholerae is a Gram-negative, comma-shaped bacterium/pathogen. The bacterium’s natural habitat is brackish or saltwater. Some strains of […]
Published
Institute for Glycomics

Institute for Glycomics Director appointed high honour of Officer of the Order of Australia

Professor Mark von Itzstein, Founder and Director of Griffith University’s Institute for Glycomics, has been awarded one of Australia’s highest honours, officially being named as an Officer (AO) of the Order of Australia in the General Division. This highly prestigious title, which took effect on 10 June 2019, was approved by the Governor-General, His Excellency […]
Published
Griffith Enterprise

Griffith University research partnership breaking new ground in the development of anti-infective drugs

Scientists from Griffith’s Institute for Glycomics have teamed up with Germany’s Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and the Hannover Medical School to explore novel anti-infective therapeutic concepts as part of the project Fraunhofer iCAIR® (Fraunhofer International Consortium for Anti-Infective Research). The project’s ground-breaking approach and research will be showcased at the Australian and German […]
Published
Australian Rivers Institute

Cheers – charge your glass with a Griffith scientist

Science will be on tap when researchers trade the lab for the pub.
Published
Griffith Enterprise

Institute for Glycomics shares in multi-million dollar grant for ground-breaking gonorrhoea research

The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has announced awards to establish four Cooperative Research Centres (CRCs) which will focus on the development of vaccines to prevent sexually transmitted infections (STIs). The grants will support collaborative, multidisciplinary research on the pathogens that cause gonorrhoea, chlamydia […]
Published
Griffith Enterprise

Glycomics Circle – empowering women in science

The Institute for Glycomics recognises the value of having women in life sciences. For centuries women have made significant contributions to society, perfectly demonstrated by the fact that 51 women in total have been awarded the Nobel Prize between 1901 and 2018, twenty of which were awarded the Nobel Prize in the fields of physics, […]
Published